A phase II study of dose-dense docetaxel and mitoxantrone in the treatment of patients with high-risk metastatic breast cancer

2002 ◽  
Vol 13 (8) ◽  
pp. 827-832 ◽  
Author(s):  
Ellen König ◽  
Christian Kurbacher ◽  
Martin Schwonzen ◽  
Martina Breidenbach ◽  
Peter Mallmann
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
High Risk ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Dose Dense

Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy

2011 ◽  
Vol 128 (2) ◽  
pp. 437-445 ◽  
Author(s):  
R. I. Lalisang ◽  
F. L. G. Erdkamp ◽  
C. J. Rodenburg ◽  
C. T. A. M. Knibbeler-van Rossum ◽  
J. W. R. Nortier ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
First Line ◽  
Randomized Phase Ii ◽  
Dose Dense

scholarly journals Phase II Study of Dehydroepiandrosterone in Androgen Receptor‐Positive Metastatic Breast Cancer

2018 ◽  
Vol 24 (6) ◽  
pp. 743 ◽  
Author(s):  
Elisabetta Pietri ◽  
Ilaria Massa ◽  
Sara Bravaccini ◽  
Sara Ravaioli ◽  
Maria Maddalena Tumedei ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Androgen Receptor ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast

Exemestane and Chemotherapy as First-line Treatment of Metastatic Breast Cancer: Results of a Phase II Study

2010 ◽  
Vol 10 (4) ◽  
pp. 313-317 ◽  
Author(s):  
Juan de la Haba-Rodriguez ◽  
Rosario González Mancha ◽  
Gumersindo Pérez Manga ◽  
Enrique Aranda Aguilar ◽  
José Manuel Baena Cañada ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study

2005 ◽  
Vol 131 (9) ◽  
pp. 568-574 ◽  
Author(s):  
Peter Schmid ◽  
Volker Heilmann ◽  
Carsten-Oliver Schulz ◽  
Annette Dieing ◽  
Silvia Lehenbauer-Dehm ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Prolonged Infusion

Phase II study of gemcitabine plus cisplatin in metastatic breast cancer

2006 ◽  
Vol 17 (5) ◽  
pp. 565-570 ◽  
Author(s):  
Homero Fuentes ◽  
German Calderillo ◽  
Francisco Alexander ◽  
Marcelino Ramirez ◽  
Enrique Avila ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast

scholarly journals Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study

2012 ◽  
Vol 23 (10) ◽  
pp. 2599-2605 ◽  
Author(s):  
R.P. Collea ◽  
F.W. Kruter ◽  
J.E. Cantrell ◽  
T.K. George ◽  
S. Kruger ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Liposomal Doxorubicin ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Pegylated Liposomal Doxorubicin

scholarly journals A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer

2004 ◽  
Vol 15 (9) ◽  
pp. 1358-1365 ◽  
Author(s):  
J. Tabernero ◽  
M.A. Climent ◽  
A. Lluch ◽  
J. Albanell ◽  
J.B. Vermorken ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Weekly Docetaxel
Sign in / Sign up

Export Citation Format

Share Document